JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2005, 54(6):256-261

Interconversion of Stereochemically Unstable Chiral Drugs: Utilization of Chromatographic Techniques for the Study of Enantiomerization, Calculation of Thermodynamic Parameters Part I: Theoretical Aspects

A. Fedurcová1, J. Lehotay1, J. Čižmárik2
1 Slovenská technická univerzita v Bratislave, Fakulta chemickej a potravinárskej technológie, Katedra analytickej chémie, SR
2 Univerzita Komenského v Bratislave, Farmaceutická fakulta, Katedra farmaceutickej chémie, SR

The paper explains the theoretical aspects of the process of enantiomerization and describes its characteristic features (generation of a plateau). In addition, some complications are presented that are produced by enantiomerization either from analytical or pharmacological points of view. It also defines the way of how to calculate energy barriers of enantiomerization according to the methods used for the separation of racemic mixtures (stopped-flow or dynamic chromatography). Mathematic models useful in deconvolution of chromatograms are also described. With the use of dynamic methods it is not possible to quantitatively evaluate the obtained chtromatograms and calculate thermodynamic parameters without computer-assisted deconvolution.

Keywords: enantiomerization; racemization; interconversion; configuration unstable drugs; kinetic rate constants

Received: April 13, 2005; Accepted: July 18, 2005; Published: June 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fedurcová A, Lehotay J, Čižmárik J. Interconversion of Stereochemically Unstable Chiral Drugs: Utilization of Chromatographic Techniques for the Study of Enantiomerization, Calculation of Thermodynamic Parameters Part I: Theoretical Aspects. Čes. slov. farm. 2005;54(6):256-261.
Download citation

References

  1. Wolf, Ch., Ghebremariam, B. T.: Tetrahedron Assymmetry, 2002; 13, 1153-1156. Go to original source...
  2. Oswald, P., Desmet, K., Sandra, P. et al.: J. Chromatogr. B, 2002; 779, 283-295. Go to original source... Go to PubMed...
  3. Tobler, E., Lämmerhofer, M., Mancini, G., Lindner, W.: Chirality, 2001; 13, 641-647. Go to original source... Go to PubMed...
  4. Bürkle, K., Karfunkel, H., Schurig, V.: J. Chromatogr, 1984; 288, 1-14 Go to original source...
  5. Trapp, O., Schurig, V.: Computers and chemistry, 2001; 25, 187-195. Go to original source... Go to PubMed...
  6. Trapp, O., Schurig, V.: J. Am. Chem. Soc., 2000; 122, 1424-1430. Go to original source...
  7. Schurig, V., Bürkle, W.: J. Am. Chem. Soc., 1982; 104, 7573-7580. Go to original source...
  8. Davankov, V. A.: Chromatographia, 1989; 27, 475-482. Go to original source...
  9. Jung, M., Schurig, V.: J. Am. Chem. Soc., 1992; 114, 529-534. Go to original source...
  10. Marriott, P., Trapp, O., Shellie, R., Schurig, V.: J. Chromatogr. A, 2001; 919, 115- 126. Go to original source... Go to PubMed...
  11. Schurig, V., Reich, S.: Chirality, 1998; 10, 316-320. Go to original source...
  12. Schoetz, G., Trapp, O., Schurig, V.: Enantiomer, 2000; 5, 391-396.
  13. Lebl, M., Gut V.: J. Chromatogr, 1983; 260, 487. Go to original source...
  14. Schurig, V., Glausch, A., Fluck, M.: Tetrahedron Asymmetry, 1995; 6, 2161-2164. Go to original source...
  15. Lai, Y-H., Marriot, P. J., Tan, B-C.: Aust. J. Chem., 1985; 38, 307-314. Go to original source...
  16. Marriot, P. J., Lai, Y-H.: Inorg. Chem., 1986; 25, 3680 až 3683. Go to original source...
  17. Jung, M.: Program SIMUL, No. 620. Quantum Chemistry program exchange. QCPE Bull., 1992; 3,12.
  18. Jung, M.: Chirality, 1994; 6, 510-512. Go to original source...
  19. Hochmuth, D. H., König, W. A.: Liebigs. Ann., 1995; 947-951. Go to original source...
  20. Schurig, V., Keller, F., Reich, S., Fluck, M.: Tetrahedron Assymmetry, 1997; 8, 3475-3480. Go to original source...
  21. Weseloh, O., Wolf, C., König, W. A.: Angew. chem. Int. Ed., 1995; 34, 1635-1636. Go to original source...
  22. Weseloh, O., Wolf, C., König, W. A.: Chirality, 1996; 8, 441-445. Go to original source...
  23. Marriot, P. J., Lai, Y.-H.: J. Chromatogr., 1988; 447, 29 až 41. Go to original source...
  24. Marriot, P. J., Lai, Y.-H.: Chem. Aust., 1994; 386-389.
  25. Roth, A., Winzer, M., Korrel, M., Wildt, H.: Liebigs. Ann., 1995; 897-919. Go to original source...
  26. Schurig, V.: J. Chromatogr. A, 2002; 965, 315-356. Go to original source... Go to PubMed...
  27. Trapp, O.: Chirality, 2002; 14, 465-470. Go to original source... Go to PubMed...
  28. Reist, M., Christiansen, L. H., Christoffersen, P. et al.: Chirality, 1995; 7, 469-473. Go to original source...
  29. Fischer, Ch., Modler, A., Moinet, Ch., Fiaud, J.-C.: J. Chromatogr. A, 1996; 728, 433-439. Go to original source...
  30. Marriott, P.: J. Chromatogr. A, 2004; 1033, 135-143. Go to original source... Go to PubMed...
  31. Reich, S., Schurig, V.: J. Microcol. Sep., 1999; 11, 475-479. Go to original source...
  32. Jacobson, J., Melander, W., Vaisnys, G., Horváth, C.: J. Phys. Chem., 1984; 88, 4536. Go to original source...
  33. Stephan, B., Zinner, H., Kastner, F., Mannschreck, A.: Chimia, 1990; 10, 336-338. Go to original source...
  34. Gasparrini, F., Misiti, D., Pierini, M., Villani, C.: Tetrahedron Assymmetry, 1997; 8, 2069-2073. Go to original source...
  35. Oxelbark, J., Allenmark, S.: J. Org. Chem., 1999; 64, 1483-1486. Go to original source... Go to PubMed...
  36. Melander, W. R., Lin, H.-J., Jacobson, J., Horváth, C.: J. Phys. Chem., 1984; 88, 4527-4536. Go to original source...
  37. Moriyasu, M., Kawanishi, K., Kato, A. et al.: Bull. Chem. Soc. Jpn., 1985; 58, 3351-3355. Go to original source...
  38. Moriyasu, M., Hashimoto, Z., Endo, M.: Bull. Chem. Soc. Jpn., 1983; 56, 1972-1977. Go to original source...
  39. Böhmer, V., Caccamese, S., Principato G., Schmidt, C.: Tetrahedron Letters, 1999; 40, 5927-5930. Go to original source...
  40. Venciana, J., Crespo, M. I.: Angew. Chem. Int. Ed., 1991; 30, 74-77. Go to original source...
  41. Cabrera, K., Jung, M., Fluck, M., Schurig, V.: J. Chromatogr. A, 1996; 731, 315-321. Go to original source...
  42. Cabrera, K., Lubda, D.: J. Chromatogr. A, 1994; 666, 433-438. Go to original source...
  43. Friaty, O., Spangler, M., Osterman, R., Schulman, L., Schwerdt, J. H.: Chirality, 1996; 8, 364-371. Go to original source...
  44. la Torre, F., Cirrili, R., Ferretti, R. et al. : Chirality, 2003; 15, 429-432. Go to original source... Go to PubMed...
  45. Cirilli, R. Costi, R., di Santo, R. et al.: J. Chromatogr. A, 2003; 993, 17-28. Go to original source... Go to PubMed...
  46. Trapp, O.: J. Biochem. Biophys. Meth., 2002; 54, 301 až 313. Go to original source... Go to PubMed...
  47. Kiesswetter, R., Brandl, F., Kastner-Pustet, N., Mannschreck, A.: Chirality, 2003; 15, S40-S49.
  48. Irurre, J., Santamaría, J., González-rego, M. C.: Chirality, 1995; 7, 154-157. Go to original source...
  49. Abatangelo, A., Zanetti, F., Navarini, L. et al.: Chirality, 2002; 14, 12-17. Go to original source... Go to PubMed...
  50. Trapp, O.: Tetrahedron Assymmetry, 2001; 12, 1395 až 1398.
  51. Oswald, P., Desmet, K., Sandra, P. et al.: Chirality, 2002; 14, 334-339. Go to original source... Go to PubMed...
  52. Wolf, C., Pirkla, W. H., Welch, C. J. et al.: J. Org. Chem., 1997; 62, 5208-5210. Go to original source...
  53. Liberek, B., Augustyniak, J., Ciarkowski, J. et al.: J. Chromatogr., 1974; 95, 223. Go to original source... Go to PubMed...
  54. Scharwächter, K. P., Hochmuth, D. H., Dittmann, H., König, W. A.: Chirality, 2001; 13, 679-690. Go to original source... Go to PubMed...
  55. Schoetz, G., Trapp, O., Schurig, V.: Anal. Chem., 2000; 72, 2758-2764. Go to original source... Go to PubMed...
  56. Kalyanam, N., Srinivasan, P. S., Manjunatha, S. G., Rijamohanan, P. R.: Tetrahedron Letters, 1993; 34, 119-122. Go to original source...
  57. Ahmed, A., Bragg, R. A., Clayden, J. et al.: Tetrahedron, 1998; 54, 13277-13294. Go to original source...
  58. Kiesswetter, R., Burgermeister, T., Mannschreck, A.: Enantiomer, 1999; 4, 289-296.
  59. Brinkmann, G., Heubes, M., Breuning, M. et al.: J. Org. Chem., 2000; 65, 722-728. Go to original source...
  60. Cannzza, G., Braghiroli, D., Baraldi, M., Parenti, C.: J. Pharm. Biomed. Anal., 2000; 23, 117-125.
  61. Cannazza, G., Braghiroli, D., Tait, A. et al.: Chirality, 2001; 13, 94-101. Go to original source...
  62. Oxelbark, J., Allenmark, S.: J. Chem. Soc., Perkin Trans 2, 1999; 1587-1589. Go to original source...
  63. Moore, J.: Physical chemistry, 4th ed. Engelwood Cliffs, NJ: Prentice Hall; 1972.
  64. Reich, S., Trapp, O., Schurig, V.: J. Chromatogr. A, 2000; 892, 487-497. Go to original source... Go to PubMed...
  65. Schurig, V., Trapp, O.: J. Chromatogr.A, 2001; 911, 167 -175. Go to original source... Go to PubMed...
  66. Trapp, O., Schoetz, G., Schurig, V.: Chirality, 2001; 13, 403-414. Go to original source... Go to PubMed...
  67. Kramer, R.: J. Chromatogr., 1975; 107, 241. Go to original source...
  68. Keller, R. A., Giddings, J. C.: J. Chromatogr., 1960; 3, 205-220. Go to original source...
  69. Cremer, E., Kramer, R.: J. Chromatogr., 1975; 107, 253. Go to original source...
  70. Rathore, A. S., Horváth, C.: Electrophoresis, 1997; 18, 2935. Go to original source... Go to PubMed...
  71. Lebl, M., Gut, V.: J. Chromatogr., 1983; 260, 478-482. Go to original source...
  72. Gasparrini, F., Lunayyi, L. Misiti, D., Villani, C.: Acc. Chem. Res., 1995; 28, 163-170. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.